Feasibility of volumetric MRI-guided high intensity focused ultrasound (MR-HIFU) for painful bone metastases

Abstract

BackgroundMagnetic resonance-guided high intensity focused ultrasound (MR-HIFU) has recently emerged as an effective treatment option for painful bone metastases. We describe here the first experience with volumetric MR-HIFU for palliative treatment of painful bone metastases and evaluate the technique on three levels: technical feasibility, safety, and initial effectiveness.MethodsIn this observational cohort study, 11 consecutive patients (7 male and 4 female; median age, 60 years; age range, 53–86 years) underwent 13 treatments for 12 bone metastases. All patients exhibited persistent metastatic bone pain refractory to the standard of care. Patients were asked to rate their worst pain on an 11-point pain scale before treatment, 3 days after treatment, and 1 month after treatment. Complications were monitored. All data were prospectively recorded in the context of routine clinical care. Response was defined as a ≥2-point decrease in pain at the treated site without increase in analgesic intake. Baseline pain scores were compared to pain scores at 3 days and 1 month using the Wilcoxon signed-rank test. For reporting, the STROBE guidelines were followed.ResultsNo treatment-related major adverse events were observed. At 3 days after volumetric MR-HIFU ablation, pain scores decreased significantly (p = 0.045) and response was observed in a 6/11 (55%) patients. At 1-month follow-up, which was available for nine patients, pain scores decreased significantly compared to baseline (p = 0.028) and 6/9 patients obtained pain response (overall response rate 67% (95% confidence interval (CI) 35%–88%)).ConclusionsThis is the first study reporting on the volumetric MR-HIFU ablation for painful bone metastases. No major treatment-related adverse events were observed during follow-up. The results of our study showed that volumetric MR-HIFU ablation for painful bone metastases is technically feasible and can induce pain relief in patients with metastatic bone pain refractory to the standard of care. Future research should be aimed at standardization of the treatment procedures and treatment of larger numbers of patients to assess treatment effectiveness and comparison to the standard of care.

Focused ultrasound for treatment of bone tumours

“…In 2014, Huisman and colleagues reported the first experience with volumetric MRgFUS for palliative treatment of painful bone metastases [51]. In this technique, the focal spot is iteratively switched to well-separated positions around a circular trajectory and sonications are repeated continuously till ablative temperatures are achieved throughout increasing diameter concentric circles.…”

The accuracy of ultrashort echo time MRI sequences for medical additive manufacturing

“…22,23 The unique feature of these novel UTE sequences is that they sample the MR signal with a minimum echo time due to radial sampling, and rapidly switch to data recording after the radiofrequency pulse has been delivered. 23 The MRI of bone using UTE sequences is being applied in several emerging clinical technologies such as positron emission tomography MRI attenuation correction, 22 high-intensity focused ultrasound applications, 24 MR-guided surgery 25 and MR-only treatment planning and guidance in radiotherapy. 26 However, to the best of our knowledge, no studies have been performed on the feasibility of UTE MRI sequences in generating STL models for AM purposes.…”

MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics

“…At 1-month follow-up (available for nine patients), a significant decrease in pain scores was observed with six of nine patients obtaining pain response (overall response rate 67%; 95% confidence interval 35-88%). 86 A bone-dedicated transducer (conformal bone system) has been developed and is currently approved by CE mark. This is a mobile multielement (1000 elements) transducer with no mechanical but electronic steering which is directly applied to the skin surface to be used as acoustic window to access the bone lesion.…”